We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

479 hedge funds and large institutions have $16.1B invested in Allergan plc in 2013 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 166 increasing their positions, 194 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $342M | Put options by funds: $171M

9% more capital invested

Capital invested by funds: $14.7B → $16.1B (+$1.39B)

6% less funds holding in top 10

Funds holding in top 10: 3230 (-2)

6% less funds holding

Funds holding: 512479 (-33)

14% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 194

31% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 94

Holders
479
Holders Change
-33
Holders Change %
-6.45%
% of All Funds
15.53%
Holding in Top 10
30
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-6.25%
% of All Funds
0.97%
New
65
Increased
166
Reduced
194
Closed
94
Calls
$342M
Puts
$171M
Net Calls
+$170M
Net Calls Change
+$45M
Name Holding Trade Value Shares
Change
Change in
Stake
DIA
201
Dana Investment Advisors
Wisconsin
$4.7M -$1.74M -13,045 -29%
Jane Street
202
Jane Street
New York
$4.63M +$2.08M +15,619 +94%
Mitsubishi UFJ Asset Management
203
Mitsubishi UFJ Asset Management
Japan
$4.55M +$482K +3,622 +13%
Nisa Investment Advisors
204
Nisa Investment Advisors
Missouri
$4.45M -$13.3K -100 -0.3%
ACM
205
Azimuth Capital Management
Michigan
$4.44M -$1.3M -9,780 -24%
LBG
206
Lloyds Banking Group
United Kingdom
$4.43M -$148K -1,110 -3%
HVIA
207
Hudson Valley Investment Advisors
New York
$4.37M -$23.3K -175 -0.6%
WBG
208
Wharton Business Group
Pennsylvania
$4.36M -$478K -3,590 -11%
Loomis, Sayles & Company
209
Loomis, Sayles & Company
Massachusetts
$4.32M -$711K -5,337 -15%
USAA
210
United Services Automobile Association
Texas
$4.24M -$2.8M -21,043 -42%
QI
211
Qualcomm Inc
California
$4.22M
DILH
212
Dai-ichi Life Holdings
Japan
$4.14M +$3.35M +25,139 +693%
CBT
213
Central Bank & Trust
Kentucky
$4.14M +$126K +944 +3%
Group One Trading
214
Group One Trading
Illinois
$3.97M +$619K +4,649 +20%
HHC
215
Hutchin Hill Capital
New York
$3.96M -$32.8M -246,300 -90%
HNB
216
Huntington National Bank
Ohio
$3.95M -$141K -1,058 -4%
CMBA
217
C.M. Bidwell & Associates
Hawaii
$3.93M +$4.66K +35 +0.1%
PNC Financial Services Group
218
PNC Financial Services Group
Pennsylvania
$3.87M +$130K +977 +4%
PAM
219
Paradigm Asset Management
New York
$3.86M -$79.9K -600 -2%
BIM
220
Bridges Investment Management
Nebraska
$3.85M +$93.2K +700 +3%
RA
221
Rational Advisors
New York
$3.85M -$2.52M -18,948 -42%
GT
222
Glenmede Trust
Pennsylvania
$3.82M -$1.21M -9,070 -25%
AAM
223
Advisors Asset Management
Colorado
$3.8M +$780K +5,857 +29%
HI
224
HBK Investments
Texas
$3.79M +$3.5M +26,311 New
DekaBank Deutsche Girozentrale
225
DekaBank Deutsche Girozentrale
Germany
$3.78M +$1.68M +12,602 +92%

AGN Hedge Fund Activity: Q3 2013 in Review

479 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2013, worth a combined $16.1B — up 9.4% from $14.7B a quarter earlier.

Sellers outnumbered buyers: 94 funds closed out of AGN and 65 opened new positions — a net loss of 29 holders — while 194 trimmed existing stakes and 166 added.

The largest buyer was Viking Global Investors, adding an estimated $244M. The largest seller was OppenheimerFunds, cutting an estimated $440M.

  • 479 institutional investors held Allergan plc (AGN) as of Q3 2013, down from 512 in Q2 2013.
  • Funds reported $16.1B of Allergan plc stock for Q3 2013, up 9.4% quarter-over-quarter.
  • 65 funds opened new Allergan plc positions in Q3 2013 and 94 closed out, a net change of -29 holders.
  • The largest Allergan plc buyer in Q3 2013 was Viking Global Investors, an estimated $244M added.
  • The largest Allergan plc seller in Q3 2013 was OppenheimerFunds, an estimated $440M sold.

Based on aggregated 13F filings for Q3 2013.